Cargando…
Elevated SH3BP5 Correlates with Poor Outcome and Contributes to the Growth of Acute Myeloid Leukemia Cells
Current strategies are not especially successful in the treatment of acute myeloid leukemia (AML). The identification and characterization of oncogenes crucial to the survival and growth of leukemia cells will provide potential targets for the exploitation of novel therapies. Herein, we report that...
Autores principales: | Li, Minjing, Hao, Shiyu, Li, Chunling, Xiao, Huimin, Sun, Liyuan, Yu, Zhenhai, Zhang, Naili, Xiong, Yanlian, Zhao, Dongmei, Yin, Yancun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770748/ https://www.ncbi.nlm.nih.gov/pubmed/31546831 http://dx.doi.org/10.3390/biom9090505 |
Ejemplares similares
-
Oligosaccharide attenuates aging‐related liver dysfunction by activating Nrf2 antioxidant signaling
por: Wang, Yueming, et al.
Publicado: (2020) -
Reciprocal interactions among Cobll1, PACSIN2, and SH3BP1 regulate drug resistance in chronic myeloid leukemia
por: Park, Kibeom, et al.
Publicado: (2022) -
hPMSCs protects against d-galactose-induced oxidative damage of CD4(+) T cells through activating Akt-mediated Nrf2 antioxidant signaling
por: Xiong, Yanlian, et al.
Publicado: (2020) -
Circulating Monocytic Myeloid-Derived Suppressor Cells Are Elevated and Associated with Poor Prognosis in Acute Myeloid Leukemia
por: Wang, Huiping, et al.
Publicado: (2020) -
The role of SH3BP2 in the pathophysiology of cherubism
por: Reichenberger, Ernst J, et al.
Publicado: (2012)